This qualitative improvement study investigates COVID-19 vaccine approvals at 3 medicine regulatory agencies in the US, EU, and Canada, characterizing and contrasting regulatory review times, and analyzing the clinical evidence supporting authorization.
No takes yet. Share an insight, caveat, or question.
Lythgoe et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: